Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors Full article
Journal |
ACS Medicinal Chemistry Letters
ISSN: 1948-5875 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Output data | Year: 2022, Volume: 13, Number: 1, Pages: 140-147 Pages count : 8 DOI: 10.1021/acsmedchemlett.1c00299 | ||||||||||
Authors |
|
||||||||||
Affiliations |
|
Cite:
Shcherbakov D.
, Baev D.
, Kalinin M.
, Dalinger A.
, Chirkova V.
, Belenkaya S.
, Khvostov A.
, Krut'ko D.
, Medved'ko A.
, Volosnikova E.
, Sharlaeva E.
, Shanshin D.
, Tolstikova T.
, Maksyutov R.
, Yarovaya O.
, Salakhutdinov N.
, Vatsadze S.
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
ACS Medicinal Chemistry Letters. 2022. V.13. N1. P.140-147. DOI: 10.1021/acsmedchemlett.1c00299 WOS OpenAlex
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
ACS Medicinal Chemistry Letters. 2022. V.13. N1. P.140-147. DOI: 10.1021/acsmedchemlett.1c00299 WOS OpenAlex
Identifiers:
Web of science: | WOS:000768206000025 |
OpenAlex: | W3204421985 |